Bavarian Nordic A/S
Bavarian Nordic A/S (BVNRY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BVNRY · as of Jun 8, 2026
Key Statistics
Explore Bavarian Nordic A/S Data
bvnry stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
bvnry competitorsBVNRY
ALFRY
BRCTF
GENSF
GLPGF
HAWPFStock Performance
Full HistoryAbout Bavarian Nordic A/S
Bavarian Nordic A/S is a Danish biopharmaceutical company specializing in the development, production, and global commercialization of essential, life-saving vaccines. Its marketed portfolio includes …
what is bavarian nordic a/s · bvnry stock overview · bavarian nordic a/s company profile · who is bavarian nordic a/s ceo · bvnry OTC · bavarian nordic a/s headquarters · bavarian nordic a/s business segments
About Stock Overview & Key Data
Bavarian Nordic A/S (BVNRY) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 3, 2013. As of the latest trading session, BVNRY stock price is $9.25, with a market capitalization of $2.1B. The stock has returned +1.09% over the past 12 months and -6.85% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Bavarian Nordic A/S stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Bavarian Nordic A/S reported revenue of $5.9B and net income of $1.3B. For detailed data — including Bavarian Nordic A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bavarian Nordic A/S (BVNRY) stock price is $9.25. The stock is traded on OTC under the ticker symbol BVNRY. The 52-week range is $8.66 – $13.00.